Doctor profile · Federal record
Dr. FREIDY EID, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · WICHITA, KS
- NPI 1629205356
- Accepts Medicare
- MIPS 15.6 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 15 locations across 1 states.
- Primary practice
-
925 N HILLSIDE ST
WICHITA, KS 672143219
(316) 616-3333
fax (316) 616-0974
Kansas — 14 locations
- Additional location
-
1124 W 21st St
Andover, KS 670025500 - Additional location
-
1300 E 5th Ave
Winfield, KS 671562407 - Additional location
-
14700 W Saint Teresa St Ste 250
Wichita, KS 672359626 - Additional location
-
14800 W Saint Teresa St
Wichita, KS 672359602 - Additional location
-
2610 N Woodlawn Blvd
Wichita, KS 672202729 - Additional location
-
3600 E Harry St
Wichita, KS 672183713 - Additional location
-
537 S Freeborn St
Marion, KS 668611256 - Additional location
-
550 N Hillside St
Wichita, KS 672144910 - Additional location
-
551 N Hillside St Ste 130
Wichita, KS 672144923 - Additional location
-
551 N Hillside St Ste 310
Wichita, KS 672144926 - Additional location
-
641 N Seneca St
Valley Center, KS 671478208 - Additional location
-
705 E Randall St
Hesston, KS 670628806 - Additional location
-
715 Medical Center Dr Ste 100
Newton, KS 671149056
(316) 804-4670
fax (316) 804-4674 - Additional location
-
929 N Saint Francis Ave
Wichita, KS 672143821
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- November 15, 2021
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Kansas #04-33695
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1629205356. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,213
Distinct HCPCS
10
Medicare allowed
$425,103
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,191 | 337 | $113 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 755 | 729 | $66 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 515 | 309 | $120 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 361 | 53 | $71 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 337 | 309 | $165 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 332 | 112 | $75 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 302 | 45 | $25 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 184 | 164 | $13 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 160 | 160 | $66 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 132 | 44 | $20 |
In context: peer comparison
Among 11 peers in this city , average services per provider: 266. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$4,088
Transactions
49
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 29 | $3,091.91 | |
| Medtronic, Inc. | 7 | $680.95 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $152.74 | |
| Novo Nordisk Inc | 3 | $62.52 | |
| Boston Scientific Corporation | 1 | $37.40 | |
| Amgen Inc. | 1 | $19.58 | |
| Novartis Pharmaceuticals Corporation | 1 | $15.60 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $13.91 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $13.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,622
Patients
641
Total drug cost
$557,488
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 410 | 68 | $311,608 |
| Furosemide | Generic | 307 | 87 | $1,665 |
| Metoprolol Tartrate | Generic | 306 | 78 | $1,616 |
| Atorvastatin Calcium | Generic | 239 | 71 | $2,159 |
| Carvedilol | Generic | 194 | 55 | $1,582 |
| Entresto (Sacubitril/Valsartan) | Brand | 181 | 27 | $153,017 |
| Metoprolol Succinate | Generic | 164 | 37 | $2,362 |
| Isosorbide Mononitrate Er (Isosorbide Mononitrate) | Brand | 137 | 34 | $1,471 |
| Potassium Chloride | Generic | 133 | 30 | $2,425 |
| Amlodipine Besylate | Generic | 124 | 34 | $854 |